Generics 7

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Imiquimod manufacturers

7 products found

Filters

7 products found

imiquimod

Cream 5 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Mexico
GMP approvals
EU GMP, COFEPRIS, INVIMA
Available for
Licensing with supply, Distribution only
Manufacturer #18696
The company has an experience of more than 80 years of medicine. It is one of the leading companies in a wide range of quality pharmaceuticals for both the prescription medication and the OTC market. They are committed to excellence, high quality, and social standards and pledge to offer quality products at accessible prices, which constitute the basis of our success.

Manufacturer usually replies in 7 days

imiquimod

Cream 3.75%; 2.5%

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16192
A pharmaceutical manufacturer based in LATAM that is active in dermatology, urology, and respiratory for 20+ years.

Manufacturer usually replies in 3 days

imiquimod

Cream 100 mg - 2 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #12677

Manufacturer usually replies in 4 days

imiquimod

Cream 3.75%, 5% - 3 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17885
The company was established in the initial of 1930s. The company’s mission is to develop and elaborate medicinal specialties of high quality and efficacy to offer trustworthy therapeutic alternatives to health professionals; in short, to offer the national and international medical community, medicines of excellence and quality

Manufacturer usually replies in 10 days

imiquimod

Cream 5 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Jordan
GMP approvals
FDA, EU GMP
Manufacturer #20751
It is specialized in manufacturing liquid and semisolid dosage forms, and hospital disinfectants. The company started in the pharmaceuticals business in the year the 1960s. They have more than 36 products and more than 10 countries. The companies are striving for a better healthy life by introducing our innovative, distinctive, and high-quality products.

Manufacturer usually replies in 19 days

imiquimod

Cream 5 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Lebanon
GMP approvals
LB
Registered in
Lebanon
Available for
Distribution only
Manufacturer #25535

Manufacturer usually replies in nan days

imiquimod

Cream 5 % - 3 g

Dossier type
CTD
Dossier status
Under development
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #30670

Manufacturer usually replies in nan days

Imiquimod

Imiquimod acts as an immune response modifier. Imiquimod is a cream prescribed to treat genital warts, Bowen's disease or squamous cell & basal cell carcinoma, secondary to surgery, as well as actinic keratosis. It is sold as a cream for self-application. It's 5% topical the cream is applied to perianal and external genital warts and small superficial basal-cell carcinomas. It cures non-hyperkeratotic and non-hypertrophic actinic keratoses affecting the face or scalp especially in immunocompetent adults when efficacy decreases by the size or number of lesions or when the patient is intolerant or not responding to cryotherapy and other topical treatments. Imiquimod is marketed as Aldara among others. 3M pharmaceuticals got the first FDA approval in 1997 as a treatment for external genital and perianal warts. As of 2015, it is generic and is available worldwide under many brands. Later, 3M was also given FDA approval to market imiquimod as a treatment for superficial basal cell carcinoma in 2004.

Dosage and treatment

Imiquimod has treatment regimes. In using to treat Actinic keratosis, it is applied two or three times a week for 4 to 6x weeks. This can be repeated as necessary after a break of a month. Three weeks before the start of treatment, the scaliest lesions are frozen with liquid nitrogen. In treating Basal cell and intraepidermal carcinoma, it is used five times a week for six weeks. In treating Genital warts, it is applied three times weekly or the 3.75% cream daily for up to 8 weeks. It is recommended to apply it less often if the reaction is excessive, and more often if no reaction occurs. In case of discontinuation, the course can be resumed after 16 weeks.

The price of Imiquimod

In the USA, the consumers have to pay an average retail price of $152.06 for a generic packet of 5% 12 packets of Cream. In the USA, the same supply costs around USD 9.

How does it work?

Imiquimod's actions stimulate innate and acquired immune responses. This ultimately results in inflammatory cell infiltration within the field of drug application. After this, apoptosis of diseased tissue happens. It does not have any direct antiviral activity but acts on the innate and adaptive immune responses both directly and indirectly. In its Direct action mode, it binds to toll-like receptors seven and eight of macrophages, monocytes, and dendritic cells and by induction of apoptosis.

Finding Imiquimod Manufacturers and Suppliers

The best way to find and gain access to Imiquimod manufacturers and Imiquimod suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Imiquimod can be a time-consuming challenge, but with Pipelinepharma's simple search engine and a network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Imiquimod to work with. You can fine-tune your search results using various filters too, letting you search for Imiquimod from specific countries.